Vieito, M., Akamatsu, H., Nakajima, T. E., Chandana, S. R., Calvo, E., SepĂșlveda, J. M., Gan, H. K., Gambardella, V., Smolenschi, C., Kim, T. M., Choudhury, N. J., Wermke, M., Palenski, T., Rivell, G., Badawi, M. A., Zhao, Y., Munasinghe, W., Jahchan, N., Hingorani, P., Papadopoulos, K. (2026). Phase 1, first-in-human (FIH) study evaluating safety and efficacy of ABBV-706: Results from patients with high-grade central nervous system (CNS) tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2041